Characteristics of subjective cognitive decline associated with amyloid positivity.
Saved in:
| Title: | Characteristics of subjective cognitive decline associated with amyloid positivity. |
|---|---|
| Authors: | Janssen O; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Jansen WJ; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Vos SJB; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Boada M; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Parnetti L; Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Gabryelewicz T; Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Fladby T; Department of Neurology, Akershus University Hospital, Lorenskog, Norway., Molinuevo JL; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Villeneuve S; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada., Hort J; Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic., Epelbaum S; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.; Inserm Sorbonne Université, Inria, Aramis project-team, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France., Lleó A; Neurology Department, Hospital de Sant Pau, Barcelona, Spain., Engelborghs S; Vrije Universiteit Brussel, (VUB) Brussels, and University of Antwerp, Antwerp, Belgium., van der Flier WM; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Landau S; Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA., Popp J; Department of Geriatric Psychiatry, Psychiatric University Hospital, Zürich, Switzerland.; Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland., Wallin A; CSIRO Health & Biosecurity, Parkville, Victoria, Australia.; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden., Scheltens P; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Rikkert MO; Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands., Snyder PJ; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Kingston, The University of Rhode Island, Rhode Island, USA., Rowe C; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia., Chételat G; Institut National de la Sant. et de la Recherche M.dicale (Inserm), Caen, France., Ruíz A; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Marquié M; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Chipi E; Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Wolfsgruber S; German Center For Neurodegenerative Diseases/Clinical Research, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Zentrum für klinische Forschung/AG, Cologne, Germany.; Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany., Heneka M; Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany., Boecker H; Functional Neuroimaging Group, Department of Radiology, University Hospital Bonn, Bonn, Germany., Peters O; Klinik für Psychiatrie und Psychotherapie, Charité Universitätsmedizin Berlin - CBF, Berlin, Deutschland., Jarholm J; Department of Neurology, Akershus University Hospital, Lorenskog, Norway., Rami L; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Tort-Merino A; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Binette AP; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada., Poirier J; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada., Rosa-Neto P; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada., Cerman J; Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic., Dubois B; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France., Teichmann M; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France., Alcolea D; Neurology Department, Hospital de Sant Pau, Barcelona, Spain., Fortea J; Neurology Department, Hospital de Sant Pau, Barcelona, Spain., Sánchez-Saudinós MB; Neurology Department, Hospital de Sant Pau, Barcelona, Spain., Ebenau J; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Pocnet C; Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland., Eckerström M; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden., Thompson L; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Kingston, The University of Rhode Island, Rhode Island, USA., Villemagne V; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia.; Department of Psychiatry, University of Pittsburgh, Pittsburgh, USA., Buckley R; Brigham and Women's Hospital and Department of Neurology Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Burnham S; Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Delarue M; Institut National de la Sant. et de la Recherche M.dicale (Inserm), Caen, France., Freund-Levi Y; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Wallin ÅK; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden., Ramakers I; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Tsolaki M; Memory and Dementia Center, 3rd Department of Neurology, 'G Papanicolau, ' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Soininen H; Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland., Hampel H; GRC no 21, Alzheimer Precision Medicine (AMP), AP-HP, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France., Spiru L; Carol DAVILA University of Medicine and Pharmacy, Bucharest, Romania.; Geriatrics- Gerontology and Old Age Psychiatry, Alzheimer Unit, Ana Aslan International Foundation - Memory Center and Longevity Medicine, Bucharest, Romania., Tijms B; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Ossenkoppele R; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Verhey FRJ; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands., Jessen F; Department of Psychiatry, University of Cologne, Cologne, Germany.; German Center For Neurodegenerative Diseases/Clinical Research, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Zentrum für klinische Forschung/AG, Cologne, Germany., Visser PJ; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. |
| Corporate Authors: | Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group, PREVENT-AD research group |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 Oct; Vol. 18 (10), pp. 1832-1845. Date of Electronic Publication: 2021 Dec 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.12512 |
